Kimberly-Clark vs Procter & Gamble KMB vs PG
Kimberly-Clark and Procter & Gamble on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.
What differs most
- Market value: Procter & Gamble $370.66B, Kimberly-Clark $36.46B.
- Debt / equity: Kimberly-Clark 3.7×, Procter & Gamble 0.7×.
- Return on equity: Kimberly-Clark 111.7%, Procter & Gamble 29.1%.
- Price / sales: Procter & Gamble 4.2×, Kimberly-Clark 2.2×.
Price return
2025-10-26 → 2026-10-26
KMB−7.8%
PG+4.9%
Profile
latestSector
Consumer Defensive
Consumer Defensive
Industry
Household & Personal Products
Household & Personal Products
Market value
$36.46B
$370.66B
Enterprise value
$42.02B
$394.22B
Employees
36,000
104,000
Revenue per employee (TTM)
$460K
$845K
Our models
nightlythe valuation on each stock's pagePrice vs model
11% undervalued vs model
17% overvalued vs model
Model range
$66.60–339
$82.89–389
Models in the headline
1
1
FCF growth priced in, at a 10% return
14.5%
14.4%
Every model, its assumptions and its range: KMB valuation · PG valuation. The growth priced in, at any return: KMB reverse DCF · PG reverse DCF.
Trading
close 2026-10-26Last close
$109.63
$159.92
52-week high
$120.66
$167.20
52-week low
$93.05
$138.04
Price vs 52-week high
−9.1%
−4.4%
Price vs 52-week low
+17.8%
+15.9%
Average daily volume / shares
1.3%
0.4%
Beta
0.28
0.38
Returns
to 2026-10-261 month
+11.4%
+9.4%
3 months
−0.1%
+8.5%
6 months
+12.0%
+7.9%
Year to date
+8.7%
+11.6%
1 year
−7.8%
+4.9%
1 year, dividends added
−3.5%
+7.7%
2 years
−19.1%
−4.9%
Valuation
KMB price × TTM to Jun 2026 · PG price × TTM to Sep 2026P/E (TTM)
18.6×
24.1×
P/E on consensus EPS (next FY)
14.9×
22.9×
Price / sales
2.2×
4.2×
EV / sales
2.5×
4.5×
EV / EBITDA
13.2×
16.1×
Price / book
20.8×
6.7×
Price / free cash flow (FY)
22.2×
24.5×
Free-cash-flow yield (FY)
4.5%
4.1%
Growth
KMB TTM and FY2025 · PG TTM and FY2026Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
−3.6%
+2.9%
Revenue, 3-year CAGR
−5.1%
2.0%
Revenue, 5-year CAGR
−2.1%
2.7%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+21.6%
+5.3%
EPS, 3-year CAGR
2.0%
3.9%
Free cash flow, 3-year CAGR
−4.1%
3.2%
Diluted shares, 3-year change
−1.5%
−2.5%
Profitability
KMB TTM to Jun 2026 · PG TTM to Sep 2026Gross margin (FY)†
35.6%
50.2%
Operating margin
12.4%
22.6%
EBITDA margin
19.2%
27.8%
Net margin
11.8%
18.2%
Free-cash-flow margin (FY)
9.5%
17.4%
Return on equity
111.7%
29.1%
Return on assets
10.5%
12.0%
Asset turnover
0.89
0.66
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.
Balance sheet
KMB MRQ Jun 2026 · PG MRQ Sep 2026Cash
$956.0M
$15.37B
Total debt
$6.52B
$38.92B
Net debt
$5.56B
$23.56B
Debt / equity
3.7×
0.7×
Net debt / EBITDA (TTM)
1.7×
1.0×
Interest coverage (FY)
9.7×
22.5×
Current ratio (FY)
0.75
0.68
Dividends
trailing 12 monthsDividend yield
4.7%
2.7%
Dividends per share
$5.10
$4.32
Payout ratio (of TTM EPS)
86.7%
65.1%
Dividend per share, 5-year CAGR
2.6%
4.9%
Frequency
Quarterly
Quarterly
Ownership and activity
last 90 days · latest 13FTracked superinvestors holding (13F)
2
10
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$0
$8.3M
Analyst upgrades
0
2
Analyst downgrades
0
2
Statements
KMB income TTM to Jun 2026 · cash flow FY2025 · PG income TTM to Sep 2026 · cash flow FY2026Revenue
$16.57B
$87.92B
EBITDA
$3.19B
$24.48B
Operating income
$2.05B
$19.83B
Net income
$1.96B
$16.03B
EPS (diluted)
$5.88
$6.64
Operating cash flow
$2.78B
$19.56B
Capital expenditure
−$1.14B
−$4.41B
Free cash flow
$1.64B
$15.15B
Dividends paid
$1.66B
$10.23B
Statements, prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.